LibreOffice is expanding its line of attack, now targeting OnlyOffice, its rival, for being "partners with Microsoft in a strategy to lock users in." The Document Foundation (TDF) has been throwing ...
Aliro aims to make your phone a universal key, bringing cross-platform tap-to-unlock and hands-free entry to compatible smart locks. Aliro aims to make your phone a universal key, bringing ...
Smart Rings Forget the Oura Ring 4 — these are the best Oura Ring alternatives in 2026 Smart Rings I've tested the best smart rings for tracking your health — and these are my favorites Phones I ...
For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...
With zero coding skills, and in a disturbingly short time, I was able to assemble camera feeds from around the world into a ...
Last year, the editors of Merriam-Webster’s dictionary anointed their word of the year as “slop,” a term denoting the low-quality flood of AI output that’s been jamming up feeds for years now. The ...
We are officially down to the final 5 days to save up to $680 on your TechCrunch Disrupt 2026 ticket. These lowest rates of the year disappear on February 27 at 11:59 p.m. PT. If you’ve been mapping ...
Super Early Bird pricing for TechCrunch Disrupt 2026 ends February 27 at 11:59 p.m. PT. That means you have just 6 days left to secure the lowest ticket prices of the year. If Disrupt has been on your ...
Anthropic pointed its most advanced AI model, Claude Opus 4.6, at production open-source codebases and found a plethora of security holes: more than 500 high-severity vulnerabilities that had survived ...
Karandeep Singh Oberoi is a Durham College Journalism and Mass Media graduate who joined the Android Police team in April 2024, after serving as a full-time News Writer at Canadian publication ...
Bitcoin BTC $74,493.24 is down sharply as trading in the new week begins, down 5% over the past 24 hours to $64,700. U.S. stock index futures are down as well, led by the Nasdaq 100's 0.9% decline.
After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate. The agreement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results